Evidence map›Paper›PMID 37283569›Full record

ArticleHemaSphere2023

SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study.

Irene Defrancesco, Virginia Valeria Ferretti, Pierre Morel, Charalampia Kyriakou, Efstathios Kastritis, Ibrahim Tohidi-Esfahani, Alessandra Tedeschi, Christian Buske, Ramón García-Sanz, Josephine M I Vos and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Irene DefrancescoDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Virginia Valeria FerrettiUOS Clinical Epidemiology and Biostatistic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Pierre MorelService d'Hematologie Clinique et Therapie Cellulaire, Centre Hospitalier Universitaire d'Amiens-Picardie, France.
Charalampia KyriakouCentre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.
Efstathios KastritisDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
Ibrahim Tohidi-EsfahaniHaematology Department, Concord Repatriation General Hospital, Sydney, NSW, Australia.
Alessandra TedeschiASST Grande Ospedale Metropolitano Niguarda Hospital, Milan, Italy.
Christian BuskeInstitute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, Germany.
Ramón García-SanzHematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Spain.
Josephine M I VosDepartment of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), the Netherlands.
Veronica PeriHematology Division, "AOU Città della Salute e della Scienza di Torino," Italy.
Gloria Margiotta CasaluciDivision of Hematology, Department of Translational Medicine, Hospital Maggiore della Carità, Novara, Italy.
Angela FerrariHematology Unit, Azienda USL-IRCCS Reggio Emilia, Italy.
Francesco PiazzaLaboratory of Myeloma and Lymphoma Pathobiology, Veneto Institute of Molecular Medicine (VIMM) and Foundation for Advanced Biomedical Research (FABR), Padua, Italy.
Rimke OostvogelsHematology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
Ester LovatoDepartment of Medicine, Hematology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Lydia MontesService d'Hematologie Clinique et Therapie Cellulaire, Centre Hospitalier Universitaire d'Amiens-Picardie, France.
Luc Matthieu ForneckerService d'Hematologie, Institut de Cancerologie Strasbourg Europe, Strasbourg, France.
Alexander GrunenbergDepartment of Internal Medicine III, University Hospital Ulm, Germany.
Meletios Athanasios DimopoulosDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
Constantine S TamPeter MacCallum Cancer Centre and University of Melbourne, VIC, Australia.
Shirley D'SaCentre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.
Veronique LeblondDépartement d'Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, France.
Judith TrotmanHaematology Department, Concord Repatriation General Hospital, Sydney, NSW, Australia.
Francesco PassamontiDepartment of Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi - ASST SetteLaghi," University of Insubria, Varese, Italy.
Luca ArcainiDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Marzia VarettoniDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37283569
PMCPMC10241499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.